Both in Pharmaceuticals
Insmed vs Jazz Pharmaceuticals
Over the past year INSM returned −39.8% and JAZZ returned +70.3%; their daily moves had a correlation of 0.13.
INSM −39.8% JAZZ +70.3%Growth of $1, one year, split-adjusted
| Metric | INSM | JAZZ |
|---|---|---|
| Price | $110.00 | $234.66 |
| Market cap | $24.13B | $15.23B |
| Today | +5.32% | +2.14% |
| 1 month | +4.5% | +1.4% |
| 6 months | −19.8% | +2.7% |
| Year to date | −36.8% | +38.0% |
| 1 year | −40.9% | +69.6% |
| Revenue growth (YoY) | +268.4% | +10.4% |
| Gross margin | 85.1% | 91.1% |
| Net margin | −19.1% | −38.9% |
| P/E (TTM) | — | 74.0× |
| Price / sales | 15.9× | 3.2× |
| Net cash | $569.9M | -$2.71B |
| Dividend yield | — | — |
| Volatility (60d) | 48.6% | 31.2% |
| Short % of float | 6.3% | 9.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).